707
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies

, ORCID Icon, &
Pages 2239-2251 | Received 27 Jan 2023, Accepted 19 Apr 2023, Published online: 27 Apr 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Radha Rani, Neha Raina, Akhilesh Kumar, Piyush K Gupta & Madhu Gupta. (2024) Advanced Nanomedicine Approach of JAK Inhibitors: Supporting Treatment of Rheumatoid Arthritis. Nanomedicine 19:4, pages 277-280.
Read now

Articles from other publishers (4)

Farnaz Bahavarnia, Mohammad Hasanzadeh, Parinaz Bahavarnia & Nasrin Shadjou. (2024) Advancements in application of chitosan and cyclodextrins in biomedicine and pharmaceutics: recent progress and future trends. RSC Advances 14:19, pages 13384-13412.
Crossref
Bartłomiej Pyrak, Karolina Rogacka-Pyrak, Tomasz Gubica & Łukasz Szeleszczuk. (2024) Exploring Cyclodextrin-Based Nanosponges as Drug Delivery Systems: Understanding the Physicochemical Factors Influencing Drug Loading and Release Kinetics. International Journal of Molecular Sciences 25:6, pages 3527.
Crossref
PALANATI MAMATHA & BHIKSHAPATHI D. V. R. N.. (2024) DETERMINATION OF IN VITRO CYTOTOXICITY OF ENTRECTINIB AND PEMIGATINIB NANOSPONGES TABLETS ON A 498, MCF-7 AND PANC-1 CELL LINES. International Journal of Pharmacy and Pharmaceutical Sciences, pages 12-16.
Crossref
MAMATHA PALANATI & D. V. R. N. BHIKSHAPATHI. (2023) DEVELOPMENT, CHARACTERIZATION AND EVALUATION OF ENTRECTINIB NANOSPONGES LOADED TABLETS FOR ORAL DELIVERY. International Journal of Applied Pharmaceutics, pages 269-281.
Crossref